1. Pink Sheet
  2. >>Pathways & Standards

FDA’s Banner Year for Drug Approvals: Time to Change the Focus

 
• By Michael McCaughan

FDA is entering a big legislative year with a good story to tell based on 30 new molecular entity approvals. But the level of submissions remains constant—suggesting it may be time to shift the focus from what comes out of FDA to what makes it in.

The Food & Drug Administration is putting its best foot forward heading into the Prescription Drug User Fee Act reauthorization in 2012.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approval Standards

More from Pathways & Standards